Blood Glucose Continuous Monitoring Articles & Analysis
14 news found
Below are the main microsphere and microneedle solutions provided by CD Formulation: Microsphere and Microneedle Patch Preparation ServicesCD Formulation's research team offers a wide range of microneedle preparations with smooth tip surfaces and clear tip details, for melatonin microneedle patch, parathyroid hormone microneedle patch, exenatide microneedle patch, insulin microneedle patch, and ...
The awarded patent, Apparatus for in vivo dielectric spectroscopy (US20200217809A1), focuses on sensor technology that is 100% non-invasive and continuously monitors blood glucose in a way that does not involve blood oxidase, but rather dielectric spectroscopy and radio frequency. ...
ByAlertgy
Alertgy, the biotech startup that’s in the race to be the first company to develop an entirely non-invasive glucose monitoring system is proud to welcome a new hire in the Engineering Department: Benjamin Freer joins Alertgy as Director of Engineering/Principal Sensor Engineer. “By far, the most exciting aspect of being on the Alertgy team is the opportunity to see a dream of mine ...
ByAlertgy
A Flexible Hybrid Electronic Wristband Sensor Platform will be developed to allow for non-invasive blood glucose monitoring, along with other sensing functionality for military personnel,” says Alertgy CEO Marc Rippen. Increased Engineering Capabilities This new location gives Alertgy 2,500 square feet to ...
ByAlertgy
Alertgy has nearly completed the process of miniaturizing its first generation NICGM® (Non-Invasive Continuous Glucose Monitor) into a smaller form factor that will be the size of modern smart watches. ...
ByAlertgy
Key Research Survey Findings: 52 percent of healthcare providers agreed motivation is a major barrier to patients adhering to blood glucose monitoring compared to only 10 percent of people with diabetes who agreed motivation is a major barrier. ...
ByLifeScan
LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced that it has named Rekha Ramesh Chief Digital and Information Officer effective immediately. ...
ByLifeScan
LifeScan, a world leader in blood glucose monitoring and digital health technology, is committed to supporting resources that help promote diabetes education and improved health management, including our most recent sponsorship of The Diabetes Way website, offering a straight-forward educational resource – even for those questions you were ...
ByLifeScan
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appointment of Valerie L. Asbury and D. Brent Shafer to the Company’s Board of Directors (“Board”), effective January 5, 2022. Ms. Asbury ...
An example of this was the UI of a blood glucose monitor, on which the decimal point, separating numbers, was difficult to decipher. The consequence of this was at home patients misreading their blood glucose levels as 22mmol/L as opposed to 2.2mmol/L and therefore administering a much larger dose of insulin than ...
There are fewer than 300,000 doctors in India actively practicing medicine. They serve hundreds of millions of patients who suffer from chronic illness in the world’s second-most populous nation. A doctor only has a few minutes to spend on a patient, remember the past diagnosis by glancing at their record and formulate a plan of management. HealthPlix, a Bangalore-based startup, believes ...
Exclusive: hopes testing can begin in 2021 on product intended to free people of need for insulin injections An Israeli company claiming to have created a tiny micro-pancreas that can “cure” diabetes for millions of people has said it will submit a request next month for human clinical trials in the UK. Betalin Therapeutics said its “bio-artificial” pancreas aims to ...
Nearly 30,000 people across the country with Type 1 diabetes have received life-changing diabetes monitors through the NHS Long Term Plan. The innovative device, which is the size of a £2 coin and worn on the arm, means people with Type 1 do not have to carry out multiple painful finger-prick checks to monitor their blood sugar levels. Instead, people with the condition can monitor their ...
Based on its recent analysis of the diabetes point-of-care (POC) diagnostics market, Frost & Sullivan recognizes Epinex Diagnostics with the 2014 Global Frost & Sullivan Award for New Product Innovation. The company's G1A™ rapid test for glycated albumin has initially the potential to bridge the gap between daily self-monitored blood glucose (SMBG) and quarterly glycated hemoglobin ...